Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss.
Husam GhanimManav BatraKelly GreenSanaa AbuayshehJeanne HejnaAntione MakdissiRobert BorowskiNitesh D KuhadiyaAjay ChaudhuriParesh DandonaPublished in: Diabetes, obesity & metabolism (2020)
Liraglutide improves glycaemia, reduces adiposity and SBP. Liraglutide also stimulates mechanisms involved with an increase in lipid oxidation and thermogenesis, while conserving lean body mass.
Keyphrases
- randomized controlled trial
- weight loss
- adipose tissue
- bariatric surgery
- study protocol
- roux en y gastric bypass
- hydrogen peroxide
- metabolic syndrome
- squamous cell carcinoma
- bone mineral density
- weight gain
- systematic review
- fatty acid
- radiation therapy
- skeletal muscle
- nitric oxide
- body composition
- physical activity
- body mass index
- lymph node
- placebo controlled
- glycemic control
- visible light